If you are a medical professional and would like to refer a patient, please direct all interested parties to our Get Started page. After completing a brief form, patients will be contacted by a CannaMD qualifying specialist who will walk them through the medical marijuana certification process.
Patient Referral Cards
CannaMD appreciates the opportunity to facilitate cannabis care as a complement to traditional treatment protocols. To help make the process as easy as possible, CannaMD has designed referral cards for convenient office distribution. To receive a complimentary box, please complete the following form.
Contact Information
CannaMD is committed to fostering a strong network of support within Florida’s medical community. We hope you won’t hesitate to reach out with any questions or inquiries.
Our staff is available via phone at 1 (855) 420-9170 or through email by completing the form on our contact page.
CannaMD also promotes active conversation on Facebook, Twitter, and Instagram.
For weekly blog updates, subscribe to the CannaMD newsletter.
Request Referral Cards
If you are a medical professional, please complete the form below to receive a complimentary box of medical cannabis appointment cards.
What Conditions Qualify
In accordance with Florida state law, the following conditions may qualify for medical marijuana treatment
Conditions That Could Qualify
According to Florida’s Amendment 2, implemented by Senate Bill 8-A, other “diagnosable, debilitating conditions of like, kind, or class” may also be eligible for a medical marijuana treatment. Possible conditions may include:
- ADHD
- Alcoholism
- Alzheimer’s
- Anorexia
- Anxiety
- Anxiolytic Use Disorder
- Arthritis (other)
- Asperger’s Disorder
- Autism
- Cannabis Use Disorder
- Cataracts
- Cerebral Palsy
- Chemotherapy Side Effects
- Chronic Nonmalignant Pain
- Chronic Pain (any kind)
- Dementia
- Depression
- Dermatomyositis
- Diabetes
- Diverticulitis
- Dystonia
- Ehlers-Danlos Syndrome
- Endometriosis
- Essential Tremor (Kinetic)
- Fibromyalgia
- GERD
- Gastroparesis
- Hepatitis C
- Hirayama Disease
- Huntington’s Disease
- Hyperemesis
- Hyperthyroidism
- Hypothyroidism
- Inflammatory Bowel Disease
- Insomnia
- Irritable Bowel Syndrome
- Lupus
- Lyme Disease
- Meniere’s Disease
- Migraine Headaches
- Muscle Spasms
- Muscular Dystrophy
- Myasthenia Gravis (MG)
- Myelodysplastic Syndromes
- Nausea
- Neuropathy
- Obesity
- Obsessive-Compulsive Disorder (OCD)
- Opioid Use Disorder
- Osteoarthritis
- Ovarian Cysts
- Overweight
- PKAN
- Psoriasis
- Radiation Therapy Side Effects
- Restless Leg Syndrome
- Rheumatoid Arthritis
- Sarcoidosis
- Seizures
- Sickle Cell Anemia
- Sleep apnea
- Spinal Cord Injury
- Stimulant Use Disorder
- Systemic Lupus Erythematosus (SLE)
- TMJ
- Tardive Dyskinesia
- Tourette’s
- Traumatic Brain Injury
- Ulcerative Colitis (UC)
- Vertigo
Research
PUBLISHED STUDIES
October 2021: CannaMD participated as recruitment site in a University of Florida (UF) study on the short and long-term effects of medical marijuana as it relates to pain. The study, conducted through UF’s College of Public Health and Health Professions and College of Medicine, was led by Department of Epidemiology Assistant Professor, Yan Wang, PhD. The final results were published in the peer-reviewed journal, Cannabis (see: “Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)”).
PRESENTED ABSTRACTS
March 2022: CannaMD‘s Chief Medical Researcher, Jessica Walters, served as a co-author on a study abstract, led by Florida Gulf Coast University and Releaf App, and presented at the 2022 Southeastern Psychological Association Conference: “Using smartphone technology to track real-time changes in anxiety/depression symptomology among Florida cannabis users”.
ONGOING STUDIES
May 2022: While multiple peer-reviewed studies have established the efficacy of medical marijuana in treating anxiety, far less is known about the specific ratio of cannabinoids that works best to alleviate anxiety symptoms. A new study – led by Florida Gulf Coast University (FGCU), Releaf App, and CannaMD – aims to shed light on the subject.
March 2022: CannaMD is proud to serve as a recruitment site for the Medical Marijuana & Me (M3) Cohort Study, a statewide survey study on MMJ outcomes among current and new MMJ patients. The study is conducted through the College of Public Health and Health Professions and the College of Medicine at UF. The project is led by Department of Epidemiology Assistant Professor Yan Wang, PhD, MSC
May 2020: CannaMD is proud to serve as a recruitment site for the Consortium for MMJ Clinical Outcomes Research Contact Registry, a statewide registry study that builds a database of MMJ patients interested in participating in research. The ongoing registry is conducted through the College of Public Health and Health Professions and the College of Medicine at UF. The project is led by Department of Epidemiology Professor Robert Cook, MD, MPH, and funded by the Consortium for MMJ Clinical Outcomes Research. Led by a leadership team at UF, the Consortium engages public and private universities across the state of Florida.
March 2020: CannaMD is proud to participate as a recruitment site in a University of Florida (UF) study on the short and long-term effects of medical marijuana as it relates to post-traumatic stress disorder (PTSD). The current study, conducted through UF’s College of Public Health & Health Professions and College of Medicine, is led by Department of Epidemiology Assistant Professor, Krishna Vaddiparti, PhD, MPE, MSW.
Press
CannaMD is actively involved in the medical community, and prides itself on serving as a local, educational resource for area physicians and and medical professionals.
For media features, please see: Press.